- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic stable plaque type psoriasis vulgaris
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 910KB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 503KB)
Calcipotriol with betamethasone – July 2023
Calcipotriol with betamethasone: Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g; Enstilar® - July 2023
Last updated
10 November 2023